HPI Clinical Studies Program

HPI Clinical Studies Program (HPI-CSP) is a multi-specialty investigator site organization located in Kingsport and Bristol, Tennessee, an area growing in reputation for providing quality investigators and a reliable patient population.

HPI-CSP presently includes more than 26 investigators, 7 coordinators, and 10 sites located within a 25-mile radius and close to a regional medical facility providing emergency and advanced medical care. Investigator specialties include Gastroenterology, Neurology, Urology, Internal Medicine, Pediatrics, Family Medicine, and General and Cardiovascular Surgery. HPI-CSP investigators are Board certified, have credentialing compliant with NCQA and JCAHO standards, and all investigators and study staff have completed IRB and GCP training. HPI-CSP investigators with previous clinical trial experience are distributed evenly throughout the infrastructure and represented on the Clinical Research Committee that oversees the Program. The Program Coordinator, with 22 years experience in the industry, provides quality assurance in development and operations. HPI-CSP is confident that this blend of experience and new enthusisam lends itself to excellence.



HPI-CSP uses a central IRB and is immediately available for Phase III and IV, Outpatient, paper and web-based trials.

Contact Details: 2550 E. Stone Drive, Suite 220, Mailbox 8 Kingsport TN 37660 United States of America Tel: 423 393 1920 Fax: 423 392 0006 Email: mary_e_geiger@wellmont.org WWW: www.cellculture.de/

Loading...

BioNews Results for HPI Clinical Studies Program:
Hollis-Eden to Present Interim Data From Its Phase I/II Clinical Studies of Apoptone(R) (HE3235) at Molecular	Genetic Engineering News:  Nov 13 2009 7:26AM Matching: clinical studies program
Hollis-Eden to Present Interim Data From Its Phase I/II Clinical Studies of Apoptone(R) (HE3235) at Molecular Targets and Cancer Therapeutics Conference	Red Orbit:  Nov 13 2009 1:26AM Matching: clinical studies program
Hollis-Eden to Present Interim Data From Its Phase I/II Clinical Studies of Apoptone(R) (HE3235) at Molecular Targets and Cancer Therapeutics Conference	Red Orbit:  Nov 13 2009 1:26AM Matching: clinical studies program
Hollis-Eden to Present Interim Data From Its Phase I/II Clinical Studies of Apoptone(R) (HE3235) at Molecular Targets and Cancer Therapeutics Conference	Red Orbit:  Nov 13 2009 1:26AM Matching: clinical studies program
Hollis-Eden to Present Interim Data From Its Phase I/II Clinical Studies of Apoptone(R) (HE3235) at Molecular Targets and Cancer Therapeutics Conference	Red Orbit:  Nov 13 2009 1:26AM Matching: clinical studies program
Promote your company here: BioNewsCast - Press Release Distribution	→View more HPI Clinical Studies Program news.

HPI Clinical Studies Program (PRW) Financial information Links from Barchart
PRW Quote from from Barchart.com
PRW Chart from from Barchart.com
PRW Profile from from Barchart.com
PRW Opinion from from Barchart.com
→View more HPI Clinical Studies Program finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 339 times since April 2007, the link to the organisation's website has been followed 47 times

Search for more companies in Kingsport

Search for more companies in TN

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for HPI Clinical Studies Program